The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018
Open accessAbstract
OBJECTIVE: To present the most recent national estimates of lung cancer burden globally in 185 countries and tobacco smoking prevalence (%) by sex. MATERIALS AND METHODS: Estimates of lung cancer incidence and mortality for 2018 were extracted from the Globocan database; observed incidence, from the last volume of Cancer Incidence in Five Continents, and tobacco prevalence, from the World Health Observatory/WHO database. RESULTS: In 2018, over two million new lung cancer cases and 1.7 million deaths were estimated to occur worldwide, representing 14% of the new cancer cases and 20% of the cancer deaths. Incidence rates showed marked variation between countries. Stable or decreasing incidence rates were predominant among males, while among females increasing rates were common. CONCLUSIONS: The continuing rise in lung cancer among women reinforces the need for strengthening implementation of the preventive actions committed to by governments in the WHO Framework Convention for Tobacco Control.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The tobacco epidemic among women remains at a less advanced phase than among men.
“In general, the tobacco epidemic among women remains at a less advanced phase than among men, and the extent to which smoking trends in women mimic those seen earlier in men varies considerably by region.13,17”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [17]
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145 · see citing works
United Nations Development Programme
Keeler, J. (2006) · Human Rights & Human Welfare · doi:10.4135/9781452218564.n704 · Cited by 4,949
Stages of the cigarette epidemic on entering its second century
Thun, M., Peto, R., Boreham, J., & Lopez, A. D. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050294 · Cited by 583 · see citing works
Avoidable global cancer deaths and total deaths from smoking
Jha, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2703 · Cited by 522 · see citing works
Guo, Y.-M., Zeng, H., Zheng, R.-S., et al. (2016) · Environmental Research · doi:10.1016/j.envres.2015.11.004 · Cited by 285
Bray, F., Tyczynski, J. E., & Parkin, D. M. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.005 · Cited by 114 · see citing works
Self-citationTrends in smoking and lung cancer mortality in Japan, by birth cohort, 1949–2010
Funatogawa, I., Funatogawa, T., & Yano, E. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.108092 · Cited by 112 · see citing works
That the effects of smoking should be measured in pack-years: misconceptions 4
Peto, J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.97 · Cited by 96 · see citing works
The effect of MPOWER on smoking prevalence
Dubray, J., Schwartz, R. M., Chaiton, M., O’Connor, S. C., & Cohen, J. E. (2014) · Tobacco Control · doi:10.1136/tobaccocontrol-2014-051834 · Cited by 72 · see citing works
Cancers attributable to tobacco smoking in France in 2015
Cao, B., Hill, C., Bonaldi, C., et al. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky077 · Cited by 40 · see citing works
Self-citationLung cancer incidence trends in Uruguay 1990–2014: An age-period-cohort analysis
Alonso, R., Piñeros, M., Laversanne, M., Musetti, C., Garau, M., Barrios, E., & Bray, F. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.04.012 · Cited by 40 · see citing works
Self-citationPiñeros, M., Sierra, M., & Forman, D. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.03.002 · Cited by 24 · see citing works
Self-citation
Flagged first, then by citations
7 of the 20 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · see citing works
“13,17 In most transitioned countries, lung cancer rates in women are still rising, 18 with only a few countries (e.g., in the United States) showing signs of a stabilization or decline in rates.”
BackgroundSelf-citationLiu, X., Yu, Y., Wang, M.-S., Mubarik, S., Wang, F., Wang, Y., Meng, R., & Yu, C. (2020) · 癌症：英文版 · doi:10.1002/cac2.12099 · Cited by 66 · see citing works
Wéber, A., Morgan, E., Vignat, J., Laversanne, M., Pizzato, M., Rumgay, H., Singh, D., Nagy, P., Kenessey, I., Soerjomataram, I., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065303 · Cited by 55 · see citing works
Self-citationKang, Y., Hadlock, T., Jolly, S., et al. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112535 · Cited by 53 · see citing works
Liu, X., Mubarik, S., Wang, F., Yu, Y., Wang, Y., Shi, F., Wen, H., & Yu, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.742076 · Cited by 48 · see citing works
Arrieta, O. G., Maldonado, F., Turcott, J. G., Zatarain-Barrón, Z. L., Barrón, F., Blake-Cerda, M., Cabrera-Miranda, L. A., Cardona, A. F., Garza, J. G. D. L., & Rosell, R. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.02.044 · Cited by 25 · see citing works
Zhang, J., Aray, B., Zhang, Y., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154619 · Cited by 21 · see citing works
Emerging Trends in Global Lung Cancer Burden
Shong, L. Y., & Lam, D. C.-L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2651-0612 · Cited by 22 · see citing works
“1,25 In most transitioned countries, lung cancer rates in women continued to rise, with only a few, such as the UnitedStates, showing stabilization ordecline.”
Zhuo, E., Cai, C., Liu, W., Li, K., & Zhao, W. (2020) · Oncology Letters · doi:10.3892/ol.2020.12253 · Cited by 19 · see citing works
“According to estimates from the World Health Organisation (WHO), ~1.7 million people died of lung cancer worldwide in 2018, accounting for 20% of all cancer‑associated deaths (5,6).”
BackgroundMethodInfluentialRetractedA pictorial review of the utility of CEUS in thoracic biopsies
Yusuf, G. T., Fang, C., Tran, S., et al. (2021) · Insights into Imaging · doi:10.1186/s13244-020-00944-w · Cited by 19 · see citing works
“Introduction Lung cancer is one of the commonest malignancies worldwide with an estimated 2 million new cases in 2018, accounting for 20% of all cancer deaths [1].”
BackgroundWang, D., Ao, J.-G., Xiong, Y., Zhang, X., & Zhang, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.868918 · Cited by 17 · see citing works
Wang, H., Sun, X., Yue, H., Yang, Y., & Feng, D. (2021) · European Journal of Cancer Care · doi:10.1111/ecc.13538 · Cited by 14 · see citing works
Arrieta, O. G., Zatarain-Barrón, Z. L., Cardona, A. F., Corrales, L., Martin, C. M., & Cuello, M. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349951 · Cited by 13 · see citing works
Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery
Sharma, P., Dhanjal, D. S., Chopra, C., Tambuwala, M. M., Sohal, S. S., van der Spek, P. J., SHARMA, H. S., & Satija, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110050 · Cited by 12 · see citing works
Wang, X., Chen, B., Xu, D., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s255586 · Cited by 12 · see citing works
Ge, Z., Liu, H., Ji, T., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1996507 · Cited by 12 · see citing works
“Non-small cell lung cancer (NSCLC) accounts for 85–90% of all cases [2,3] and is typically classified into three categories: atypical adenomatous/adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive adenocarcinoma [4].”
BackgroundRetractedLiu, H., Yang, P., Li, X., & Jia, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11898 · Cited by 11 · see citing works
Mild exposure to fine particulate matter promotes angiogenesis in non-small cell lung carcinoma
Ji, S. M., Choi, J., Lee, J. Y., Kim, S., Bae, W., Jang, Y. W., Kim, J., Lee, S. H., Nam, S., & Jeong, J. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121715 · Cited by 11 · see citing works
Risk factors for the development of lung cancer around the world: a review
Agonsanou, H., Figueiredo, R., & Bergeron, M. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00201 · Cited by 9 · see citing works
Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
Gao, G., & Zhang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1542844 · Cited by 8 · see citing works
Pettit, N., Al-Hader, A. A., & Thompson, C. A. (2021) · Current Problems in Cancer Case Reports · doi:10.1016/j.cpccr.2021.100059 · Cited by 8 · see citing works
Schneider, I. J. C., Schmidt, T. P., Corrêa, V. P., et al. (2022) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2022056003651 · Cited by 7 · see citing works
“0) 28 (1,0) 17 (60,7) 39,3 (21,7–56,5) Ano do diagnóstico 0,623 0,690 2008 514 (18,2) 257 (50,0) 50,0 (45,6–54,2) 2009 575 (20,3) 298 (51,8) 48,2 (44,0–52,2) 2010 597 (21,1) 316 (52,9) 47,1 (43,0–51,0) 2011 542 (19,2) 285 (52,5) 47,5 (43,3–51,6) 2012 600 (21,2) 294 (49,0) 51,0 (46,9–54,9) Status Censura 1.”
InfluentialSleep-disordered breathing and risk of lung cancer: a meta-analysis longitudinal follow-up studies
Ma, H., Zhang, X., Han, J., et al. (2021) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000707 · Cited by 7 · see citing works
“7 million in 2018 for people all over the world (Miranda-Filho et al., 2019).”
BackgroundInfluentialOxidative stress induction by OCPs and OPPs pesticides may cause lung cancer incidence
Asadikaram, G., Pourghadamyari, H., Abolhassani, M., et al. (2023) · Toxin Reviews · doi:10.1080/15569543.2023.2282494 · Cited by 6 · see citing works
СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ ЭПИДЕМИОЛОГИИ И ФАКТОРАХ РИСКА РАЗВИТИЯ РАКА ЛЕГКОГО. ОБЗОР ЛИТЕРАТУРЫ
Мухамбетжан, А. Ж., Urazayeva, S. T., Urazayev, O., et al. (2020) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2020.22.2.003 · Cited by 6 · see citing works
Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients
Song, L., Zhu, Z., Wu, H., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07331-5 · Cited by 6 · see citing works
Mollaei, H., Karimi, F., Ghorbany, M., Hosseinzadeh, M. S., Moudi, M., & Kouhi, S. M. M. (2021) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb.121089 · Cited by 5 · see citing works
Marshall, K. L., Twum, Y., & Gao, W. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03426-8 · Cited by 5 · see citing works
PATIL, M., & Patel, P. H. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i1.46611 · Cited by 3 · see citing works
La carga del cáncer a nivel mundial: patrones para la toma de decisiones
Piñeros, M., Vignat, J., Wiesner, C., et al. (2021) · Medicina · doi:10.56050/01205498.1565 · Cited by 3 · see citing works
Self-citationKatushabe, C., Kumaran, S., & Masabo, E. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17799 · Cited by 3 · see citing works
Chan, E. W. C., Wong, C. W., Wong, S. K., et al. (2020) · Journal of Chinese Pharmaceutical Sciences · doi:10.5246/jcps.2020.01.001 · Cited by 3 · see citing works
Oxidative Stress Induction By Pesticides May Cause Lung Cancer IncidencePreprint
Asadikaram, G., Pourghdamyari, H., Abolhassani, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1204945/v1 · Cited by 3 · see citing works
Exploring the Issue of Tobacco Epidemic and Impairment of Lung Health
Shrivastava, S. R., & Shrivastava, P. (2019) · MAMC Journal of Medical Sciences · doi:10.4103/mamcjms.mamcjms_71_19 · Cited by 2 · see citing works
Yang, Y., Alahmadi, T. A., Alharbi, S. A., & Wainwright, M. (2023) · Materials Express · doi:10.1166/mex.2023.2409 · Cited by 1 · see citing works
Xiang, R., Hu, P., Xiao, X., Li, W., Liao, X., Li, J., Zhu, W., Liu, X., & Li, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1566195 · Cited by 1 · see citing works
Zhang, T., Zhang, D., Zeng, J., et al. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1776875 · Cited by 1 · see citing works
Liu, F., Dai, L., Wang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-958972/v1
Area, K. F. R. (2005)
Liu, F., Dai, L., Wang, Y., Liu, M., Wang, M., Zhou, Z., Qi, Y., Chen, R., Ouyang, S., & Fan, Q. (2022) · Journal of Surgical Oncology · doi:10.1002/jso.27072
ВПЛИВ ШИЙНОЇ МЕДІАСТИНОСКОПІЇ НА ВИБІР ОПТИМАЛЬНОЇ ТАКТИКИ ЛІКУВАННЯ РАКУ ЛЕГЕНЬ
Верещако, Р., Земсков, С., Петренко, В., et al. (2023) · Перспективи та інновації науки · doi:10.52058/2786-4952-2023-12(30)-895-904
Zhāng, P., Zhang, X., & Kang, L. (2023) · Materials Express · doi:10.1166/mex.2023.2480
牟, 康. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151147
Monotropein represses the proliferation and angiogenesis via the AKT/NF-κB pathway in lung cancer
Cai, B., Ma, B., Zhang, S., et al. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03810-y
“Lung cancer can be caused by tobacco, environmental exposures, biomass fuels, and pollution, and tobacco is the principal cause of lung cancer (Miranda-Filho et al. 2019).”
Liskova, V., Liška, J., Molnarova, N., Nechutna, L., Topolčan, O., Pecen, L., Zedníková, I., Skalický, T., & Moláček, J. (2026) · World Journal of Surgical Oncology · doi:10.1186/s12957-026-04317-3
“Lung cancer that is associated with smoking, historically specific to males, is increasing in females in recent generations in Europe and North America [3, 27–31].”
Mansoor, J., Shakil, M., Aqil, H., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121238
- Authors
- Miranda-Filho, A., Piñeros, M., & Bray, F.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- Venue
- Salud Pública de México
- Publisher
- Instituto Nacional de Salud Publica
- Published
- 2019-06-07
- Volume
- 61
- Issue
- 3, may-jun
- Pages
- 219
- ISSN
- 0036-3634 (ISSN-L)
- 1606-7916
- OpenAlex
- W2951112113
- Cited by
- 47
- References
- 20
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 1 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 1
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Salud Pública de México (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- lung cancer, tobacco control, smoking prevalence, lung cancer incidence, lung cancer mortality, global cancer burden, sex differences in cancer incidence, Framework Convention on Tobacco Control, cancer prevention
- MeSH terms
- Smoking Prevention, Adolescent, Adult, Female, Humans, Lung Neoplasms, Male, Smoking, Global Health, Incidence, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
